TGFB1 and malignant colon neoplasm: Germann et al. have seen that peripheral blood NDGs from patients with colon cancer inhibit T-cell proliferation, and that the inhibitory effect can be rescued through the addition of a transforming growth factor beta (TGF-β) inhibitor.